Hasil Pencarian - Keiko Ashidate

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Correction: Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study

    Correction: Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study oleh Yoshiki Ishibashi, Rie Nishitani, Akiyoshi Shimura, Ayano Takeuchi, Mamoru Touko, Takashi Kato, Sahoko Chiba, Keiko Ashidate, Nobuo Ishiwata, Tomoyasu Ichijo, Masataka Sasabe

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Correction: Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study.

    Correction: Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study. oleh Yoshiki Ishibashi, Rie Nishitani, Akiyoshi Shimura, Ayano Takeuchi, Mamoru Touko, Takashi Kato, Sahoko Chiba, Keiko Ashidate, Nobuo Ishiwata, Tomoyasu Ichijo, Masataka Sasabe

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study.

    Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study. oleh Yoshiki Ishibashi, Rie Nishitani, Akiyoshi Shimura, Ayano Takeuchi, Mamoru Touko, Takashi Kato, Sahoko Chiba, Keiko Ashidate, Nobuo Ishiwata, Tomoyasu Ichijo, Masataka Sasabe

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study

    Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study oleh Yoshiki Ishibashi, Rie Nishitani, Akiyoshi Shimura, Ayano Takeuchi, Mamoru Touko, Takashi Kato, Sahoko Chiba, Keiko Ashidate, Nobuo Ishiwata, Tomoyasu Ichijo, Masataka Sasabe, Amir Radfar

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects

    Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects oleh Kentaro Sakamoto, Mitsunobu Kawamura, Takayuki Watanabe, Keiko Ashidate, Takahide Kohro, Akira Tanaka, Yasumichi Mori, Motoki Tagami, Tsutomu Hirano, Tsutomu Yamazaki, Teruo Shiba, RESEARCH Study Group

    Diterbitkan 2017-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.

    Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins. oleh Kentaro Sakamoto, Mitsunobu Kawamura, Takahide Kohro, Masao Omura, Takayuki Watanabe, Keiko Ashidate, Toshiyuki Horiuchi, Hidehiko Hara, Nobuo Sekine, Rina Chin, Motoyoshi Tsujino, Toru Hiyoshi, Motoki Tagami, Akira Tanaka, Yasumichi Mori, Takeshi Inazawa, Tsutomu Hirano, Tsutomu Yamazaki, Teruo Shiba, RESEARCH Study Group

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: